thisdrug what a medicine's name tells you

WHO naming stem · suffix · 222 listed names

-tinib

This page was written with AI.

tyrosine kinase inhibitors

WHO's definition, quoted as written in the 2024 stem book

75 of 222 names appear in these lists: 72 in the US list (FDA Drugs@FDA) and 64 in the EU central list (EMA); 61 have national brands in at least one EU/EEA country.

Names only. This page is about -tinib as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -tinib. So the letters tinib sit at the end of the name (…tinib).

All 222 names WHO lists under -tinib

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 75 of 222 names appear in these lists: 72 in the US list (FDA Drugs@FDA) and 64 in the EU central list (EMA); 61 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.

  1. abivertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  2. abrocitinib
    US brands: CIBINQO
    EU (central) brands: Cibinqo
  3. acalabrutinib
    US brands: CALQUENCE
    EU (central) brands: Calquence
  4. adrixetinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  5. afatinib
    US brands: GILOTRIF
    EU (central) brands: Giotrif
  6. alectinib
    US brands: ALECENSA
    EU (central) brands: Alecensa
  7. altiratinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  8. amuvatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  9. anizatrectinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  10. ansornitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  11. atinvicitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  12. atuzabrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  13. aumolertinib
    US brands: none found
    EU (central) brands: Aumseqa
  14. avapritinib
    US brands: AYVAKIT
    EU (central) brands: Ayvakyt
  15. avutometinib
    US brands, in combination: AVMAPKI FAKZYNJA CO-PACK (COPACKAGED) with defactinib
    EU (central) brands: none found
  16. axitinib
    US brands: INLYTA
    EU (central) brands: Axitinib Accord, Inlyta
  17. bafetinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  18. baricitinib
    US brands: OLUMIANT
    EU (central) brands: Olumiant
  19. befotertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  20. belizatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  21. bemcentinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  22. beprocitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  23. bezuclastinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  24. binimetinib
    US brands: MEKTOVI
    EU (central) brands: Mektovi
  25. boditrectinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  26. bosutinib
    US brands: BOSULIF
    EU (central) brands: Bosulif
  27. branebrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  28. brigatinib
    US brands: ALUNBRIG
    EU (central) brands: Alunbrig
  29. cabozantinib
    US brands: RESNIBEN
    EU (central) brands: Cabometyx, Cometriq
  30. canertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  31. capmatinib
    US brands: TABRECTA
    EU (central) brands: Tabrecta
  32. catequentinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  33. cerdulatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  34. ceritinib
    US brands: ZYKADIA
    EU (central) brands: Zykadia
  35. cobimetinib
    US brands: COTELLIC
    EU (central) brands: Cotellic
  36. conteltinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  37. crizotinib
    US brands: XALKORI
    EU (central) brands: Xalkori
  38. dacomitinib
    US brands: VIZIMPRO (discontinued in FDA listings)
    EU (central) brands: Vizimpro
  39. dalmelitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  40. darizmetinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  41. dasatinib
    US brands: PHYRAGO, SPRYCEL
    EU (central) brands: Dasatinib Accord Healthcare, Sprycel, Dasatinib Accord (withdrawn), Dasatinib Accordpharma (withdrawn)
  42. decernotinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  43. defactinib
    US brands, in combination: AVMAPKI FAKZYNJA CO-PACK (COPACKAGED) with avutometinib
    EU (central) brands: none found
  44. delgocitinib
    US brands: ANZUPGO
    EU (central) brands: Anzupgo
  45. denfivontinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  46. derazantinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  47. deucravacitinib
    US brands: SOTYKTU
    EU (central) brands: Sotyktu
  48. deuruxolitinib
    US brands: LEQSELVI
    EU (central) brands: none found
  49. dovitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  50. dubermatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  51. ebezotinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  52. edicotinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  53. edralbrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  54. elenestinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  55. elsubrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  56. elzovantinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  57. emzeltrectinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  58. ensartinib
    US brands: ENSACOVE
    EU (central) brands: none found
  59. entospletinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  60. entrectinib
    US brands: ROZLYTREK
    EU (central) brands: Rozlytrek
  61. epertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  62. erdafitinib
    US brands: BALVERSA
    EU (central) brands: Balversa
  63. erlotinib
    US brands: TARCEVA (discontinued in FDA listings)
    EU (central) brands: Tarceva
  64. evobrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  65. famitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  66. fedratinib
    US brands: INREBIC
    EU (central) brands: Inrebic
  67. fenebrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  68. filgotinib
    US brands: none found
    EU (central) brands: Jyseleca
  69. fisogatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  70. flumbatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  71. foretinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  72. fosifidancitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  73. fostamatinib
    US brands: TAVALISSE
    EU (central) brands: Tavlesse
  74. fruquintinib
    US brands: FRUZAQLA
    EU (central) brands: Fruzaqla
  75. futibatinib
    US brands: LYTGOBI
    EU (central) brands: Lytgobi
  76. gandotinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  77. gefitinib
    US brands: IRESSA
    EU (central) brands: Iressa, Gefitinib Mylan (withdrawn)
  78. gemnelatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  79. gilteritinib
    US brands: XOSPATA
    EU (central) brands: Xospata
  80. glesatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  81. golidocitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  82. golvatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  83. gumarontinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  84. gunagratinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  85. gusacitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  86. ibrutinib
    US brands: IMBRUVICA
    EU (central) brands: Imbruvica
  87. ifebemtinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  88. ifidancitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  89. ilginatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  90. ilunocitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  91. imatinib
    US brands: GLEEVEC, IMKELDI
    EU (central) brands: Glivec, Imatinib Accord, Imatinib Teva, Imatinib Actavis (withdrawn), Imatinib Koanaa (withdrawn), Imatinib medac (withdrawn), Imatinib Teva B.V. (withdrawn)
  92. infigratinib
    US brands: TRUSELTIQ (discontinued in FDA listings)
    EU (central) brands: none found
  93. itacitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  94. ivarmacitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  95. izencitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  96. lapatinib
    US brands: TYKERB
    EU (central) brands: Tyverb
  97. larotrectinib
    US brands: VITRAKVI
    EU (central) brands: Vitrakvi
  98. lazertinib
    US brands: LAZCLUZE
    EU (central) brands: Lazcluze
  99. lenvatinib
    US brands: LENVIMA
    EU (central) brands: Kisplyx, Lenvima
  100. lestaurtinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  101. linsitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  102. lirafugratinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  103. lorlatinib
    US brands: LORBRENA
    EU (central) brands: Lorviqua
  104. lorpucitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  105. luxeptinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  106. masitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  107. mavelertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  108. merestinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  109. mifanertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  110. milrebrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  111. mirdametinib
    US brands: GOMEKLI
    EU (central) brands: Ezmekly
  112. mivavotinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  113. mobocertinib
    US brands: EXKIVITY (discontinued in FDA listings)
    EU (central) brands: none found
  114. momelotinib
    US brands: OJJAARA
    EU (central) brands: Omjjara
  115. mubritinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  116. naquotinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  117. narmafotinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  118. nazartinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  119. nemtabrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  120. neratinib
    US brands: NERLYNX
    EU (central) brands: Nerlynx
  121. nezulcitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  122. nilotinib
    EU (central) brands: Nilotinib Accord, Tasigna
  123. nimucitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  124. oclacitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  125. olafertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  126. olverembatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  127. orantinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  128. orelabrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  129. osimertinib
    US brands: TAGRISSO
    EU (central) brands: Tagrisso
  130. pacritinib
    US brands: VONJO
    EU (central) brands: none found
  131. paltimatrectinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  132. pamufetinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  133. peficitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  134. pegcantratinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  135. pelitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  136. pemigatinib
    US brands: PEMAZYRE
    EU (central) brands: Pemazyre
  137. pexidartinib
    US brands: TURALIO
    EU (central) brands: none found
  138. pexmetinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  139. pirtobrutinib
    US brands: JAYPIRCA
    EU (central) brands: Jaypirca
  140. ponatinib
    US brands: ICLUSIG
    EU (central) brands: Iclusig
  141. poseltinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  142. povorcitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  143. poziotinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  144. pralsetinib
    US brands: GAVRETO
    EU (central) brands: Gavreto (withdrawn)
  145. pumecitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  146. quizartinib
    US brands: VANFLYTA
    EU (central) brands: Vanflyta
  147. radotinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  148. ralimetinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  149. rebastinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  150. refametinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  151. remibrutinib
    US brands: RHAPSIDO
    EU (central) brands: Rhapsido
  152. repotrectinib
    US brands: AUGTYRO
    EU (central) brands: Augtyro
  153. resencatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  154. rezivertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  155. rilzabrutinib
    US brands: WAYRILZ
    EU (central) brands: Wayrilz
  156. ripretinib
    US brands: QINLOCK
    EU (central) brands: Qinlock
  157. risvodetinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  158. ritlecitinib
    US brands: LITFULO
    EU (central) brands: Litfulo
  159. roblitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  160. rociletinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  161. rogaratinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  162. ropsacitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  163. rovadicitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  164. ruserontinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  165. ruxolitinib
    EU (central) brands: Jakavi, Opzelura
  166. sacibertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  167. sapitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  168. saracatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  169. savolitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  170. selitrectinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  171. selpercatinib
    US brands: RETEVMO
    EU (central) brands: Retsevmo
  172. selumetinib
    US brands: KOSELUGO
    EU (central) brands: Koselugo
  173. seralutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  174. sitravatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  175. sofnobrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  176. solcitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  177. sotuletinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  178. spebrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  179. sunitinib
    US brands: SUTENT
    EU (central) brands: Sunitinib Accord, Sutent
  180. sunvozertinib
    US brands: ZEGFROVY
    EU (central) brands: none found
  181. surufatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  182. taletrectinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  183. tamnorzatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  184. tandutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  185. tarloxotinib bromide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  186. tasurgratinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  187. telatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  188. tepotinib
    US brands: TEPMETKO
    EU (central) brands: Tepmetko
  189. tesevatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  190. tinengotinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  191. tirabrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  192. tivantinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  193. tofacitinib
    US brands: XELJANZ, XELJANZ XR
    EU (central) brands: Xeljanz
  194. tolebrutinib
    US brands: none found
    EU (central) brands: Cenrifki
  195. trametinib
    US brands: MEKINIST
    EU (central) brands: Mekinist, Spexotras
  196. tucatinib
    US brands: TUKYSA
    EU (central) brands: Tukysa
  197. tunlametinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  198. tuspetinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  199. tuxobertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  200. unecritinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  201. upadacitinib
    US brands: RINVOQ, RINVOQ LQ
    EU (central) brands: Rinvoq
  202. utatrectinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  203. vamotinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  204. varlitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  205. vebreltinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  206. vecabrutinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  207. vepafestinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  208. vimseltinib
    US brands: ROMVIMZA
    EU (central) brands: Romvimza
  209. vodobatinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  210. xiliertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  211. zanubrutinib
    US brands: BRUKINSA
    EU (central) brands: Brukinsa
  212. zanzalintinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  213. zapnometinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  214. zasocitinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  215. zeteletinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  216. zidesamtinib
    US brands: JIDEYTRO
    EU (central) brands: none found
  217. zipalertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  218. zoligratinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  219. zongertinib
    US brands: HERNEXEOS
    EU (central) brands: none found
  220. zorifertinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  221. zunsemetinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  222. zurletrectinib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)

US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.

EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.

EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.

Decode another name

Decoded

afatinib

Listed INNCarries the WHO stem -tinib

  • -tinibend of the nameWHO lists it hereWHO definition: tyrosine kinase inhibitors

“afatinib” is an INN that WHO lists under -tinib in the 2024 stem book. WHO’s 2024 stem book lists “afatinib” under -ertinib as a name of the same group of substances in which the stem is not used (group c).

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -tinib (Part II B) and the 222 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.

Made with AI tools. · Privacy